Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective
- PMID: 20956822
- PMCID: PMC5161070
- DOI: 10.1093/jncimonographs/lgq018
Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective
Abstract
Ductal carcinoma in situ (DCIS) is a disease whose manifestations are largely confined to in-breast pathology. Management strategies therefore focus on various combinations of local therapy: mastectomy, lumpectomy alone, and lumpectomy followed by breast irradiation. Although DCIS does not carry an inherent risk of distant organ metastasis, optimal local control is essential because any in-breast or chest wall recurrence may occur as an invasive lesion. Local recurrence has been reported following breast-conserving surgery as well as mastectomy. Breast radiation is therefore generally recommended following breast-conserving surgery, and in selected circumstances, mastectomy may be the preferred treatment strategy. This article reviews the surgical and associated clinicopathologic issues related to initial biopsy and perioperative planning that should be considered for all DCIS cases to optimize local control.
Similar articles
-
Ductal carcinoma in situ, complexities and challenges.J Natl Cancer Inst. 2004 Jun 16;96(12):906-20. doi: 10.1093/jnci/djh164. J Natl Cancer Inst. 2004. PMID: 15199110 Review.
-
The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.J Natl Cancer Inst Monogr. 2010;2010(41):130-3. doi: 10.1093/jncimonographs/lgq022. J Natl Cancer Inst Monogr. 2010. PMID: 20956816 Free PMC article. Review.
-
The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast.J Natl Cancer Inst Monogr. 2010;2010(41):187-92. doi: 10.1093/jncimonographs/lgq020. J Natl Cancer Inst Monogr. 2010. PMID: 20956827 Free PMC article. Review.
-
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.J Natl Cancer Inst. 2011 Mar 16;103(6):478-88. doi: 10.1093/jnci/djr027. Epub 2011 Mar 11. J Natl Cancer Inst. 2011. PMID: 21398619 Free PMC article. Clinical Trial.
-
Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):3-9. doi: 10.1016/0360-3016(94)90512-6. Int J Radiat Oncol Biol Phys. 1994. PMID: 8083125 Clinical Trial.
Cited by
-
Impact of Histopathological Factors, Patient History and Therapeutic Variables on Recurrence-free Survival after Ductal Carcinoma in Situ: 8-Year Follow-up and Questionnaire Survey.Geburtshilfe Frauenheilkd. 2016 Jan;76(1):46-52. doi: 10.1055/s-0041-110805. Geburtshilfe Frauenheilkd. 2016. PMID: 26855440 Free PMC article.
-
Role of the radiotherapy boost on local control in ductal carcinoma in situ.Int J Surg Oncol. 2012;2012:748196. doi: 10.1155/2012/748196. Epub 2012 Apr 8. Int J Surg Oncol. 2012. PMID: 22577533 Free PMC article.
-
Investigational Paradigms in Downscoring and Upscoring DCIS: Surgical Management Review.Int J Surg Oncol. 2012;2012:560493. doi: 10.1155/2012/560493. Epub 2012 May 16. Int J Surg Oncol. 2012. PMID: 22666571 Free PMC article.
References
-
- Fisher ER, Leeming R, Anderson S, Redmond C, Fisher B. Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators. J Surg Oncol. 1991;47(3):139–147. - PubMed
-
- Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet. 2000;355(9203):528–533. - PubMed
-
- Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol. 2001;19(8):2263–2271. - PubMed
-
- Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer. 1999;86(3):429–438. - PubMed
-
- Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16(2):441–452. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical